在儿科急性严重喘中释放气道警报器IL-33和TSLP:一项病例对照研究
M Ramphul1, I C Scott2, H Killick2
1Department of Paediatric Respiratory Medicine, Leicester Children's Hospital. Leicester Royal Infirmary, Leicester, UK.
Acta paediatrica (Oslo, Norway : 1992)
|December 12, 2025
概括
在儿童喘发作期间,介质素 (IL) -33和胸膜 stromal 淋巴蛋白 (TSLP) 警示蛋白显著升高. 这些发现表明,预防儿童严重喘恶化可能是潜在的治疗点.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞因子生物学 细胞因子生物学
背景情况:
- 儿童发病的喘与呼吸道警示因特鲁金 (IL) - 33和胸膜层淋巴质素 (TSLP) 有关.
- 了解喘恶化期间的警报水平对于向治疗至关重要.
研究的目的:
- 量化患有喘发作的儿童和青少年 (CYP) 的气道中的IL-33和TSLP水平.
- 为了比较急性喘,稳定性喘和非喘对照组之间的警示素-细胞因子度.
主要方法:
- 一个前性的,观察性的,案例控制的可行性研究设计.
- 使用高灵敏度免疫测试来测量吐中的IL-33和TSLP度.
- 参与者包括急性喘发作,稳定的喘和健康对照的CYP.
主要成果:
- 与稳定喘患者相比,急性喘患者的液IL-33和TSLP水平分别高3.4倍和17.7倍.
- 在稳定喘患者和非喘对照之间没有观察到唾液IL-33和TSLP的显著差异.
- 升高的警示剂水平是儿童急性喘恶化的特征.
结论:
- 在儿童急性严重喘发作期间,IL-33和TSLP显著增加.
- 这些升高的警示素可能会导致儿童喘恶化期间持续的呼吸道炎症和重塑.
- 这些发现支持对抗TSLP和抗IL-33生物药物的临床研究,用于治疗儿童喘发作.
更多相关视频
11:07Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
Published on: July 6, 2019
26.5K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Breathing
64.1K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.1K
